Medication Barriers and Challenges Experienced/Perceived by Caregivers in Pediatric Medication Management: A Scoping

Anmol Toor1, Tapanga Brooks1, Andrea W Tang1

  • 1College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, SK, Canada.

Insights

Non-professional caregivers face significant challenges managing pediatric medications. Addressing drug factors and caregiver knowledge gaps is crucial for improving medication administration success in children with chronic conditions.

Area of Science:

  • Pediatric Pharmacology
  • Caregiver Support
  • Chronic Disease Management

Background:

  • Managing medications for pediatric patients with chronic diseases presents unique challenges for non-professional caregivers.
  • Understanding these barriers is essential for improving treatment adherence and outcomes.

Purpose of the Study:

  • To identify and categorize the challenges and barriers non-professional caregivers (e.g., parents) encounter when managing medications for pediatric patients with chronic conditions in outpatient settings.

Main Methods:

  • A scoping review was conducted using Embase and Ovid Medline databases, adhering to Joanna Briggs Institute methodology and PRISMA-SCr guidelines.
  • Evidence selection and data extraction were performed independently by two reviewers.
  • Thematic analysis was used to group and theme identified medication barriers.

Main Results:

  • Eight articles were included, identifying 20 medication barriers categorized into drug factors, drug burden/regimen, access, caregiver, child, healthcare system, and fear/stigma.
  • Drug factors constituted 25% of barriers, followed by caregiver factors (20%).
  • Key barriers included drug formulation, caregiver knowledge, and forgetfulness.

Conclusions:

  • Non-professional caregivers face substantial medication management challenges.
  • Future research should prioritize interventions targeting drug formulation, caregiver knowledge, and memory aids to enhance pediatric medication administration success.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
391
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
102
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
851
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
360
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
505
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
368